CO5180632A1 - Composicion farmaceutica dos de tiazolidindiona u oxazolidindiona y derivados de in- dol. - Google Patents

Composicion farmaceutica dos de tiazolidindiona u oxazolidindiona y derivados de in- dol.

Info

Publication number
CO5180632A1
CO5180632A1 CO00065981A CO00065981A CO5180632A1 CO 5180632 A1 CO5180632 A1 CO 5180632A1 CO 00065981 A CO00065981 A CO 00065981A CO 00065981 A CO00065981 A CO 00065981A CO 5180632 A1 CO5180632 A1 CO 5180632A1
Authority
CO
Colombia
Prior art keywords
group
hydrogen atom
lower alkyl
atom
halogen
Prior art date
Application number
CO00065981A
Other languages
English (en)
Spanish (es)
Inventor
Sudo Katsuichi
Wada Yasuhiko
Sugiyama Yasuo
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of CO5180632A1 publication Critical patent/CO5180632A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO00065981A 1999-09-03 2000-09-01 Composicion farmaceutica dos de tiazolidindiona u oxazolidindiona y derivados de in- dol. CO5180632A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25044399 1999-09-03
JP2000056021 2000-02-28

Publications (1)

Publication Number Publication Date
CO5180632A1 true CO5180632A1 (es) 2002-07-30

Family

ID=26539777

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00065981A CO5180632A1 (es) 1999-09-03 2000-09-01 Composicion farmaceutica dos de tiazolidindiona u oxazolidindiona y derivados de in- dol.

Country Status (14)

Country Link
EP (1) EP1212090A2 (ko)
KR (1) KR20020063555A (ko)
CN (1) CN1372476A (ko)
AR (1) AR031674A1 (ko)
AU (1) AU6868000A (ko)
CA (1) CA2383946A1 (ko)
CO (1) CO5180632A1 (ko)
HK (1) HK1044711A1 (ko)
HU (1) HUP0203285A3 (ko)
NO (1) NO20021036L (ko)
PE (1) PE20010580A1 (ko)
PL (1) PL354295A1 (ko)
RU (1) RU2002108346A (ko)
WO (1) WO2001017513A2 (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051441A1 (fr) * 2000-12-26 2002-07-04 Sankyo Company, Limited Compositions medicinales contenant un diuretique et un agent renforçant la resistance a l'insuline
WO2002080936A1 (en) 2001-04-04 2002-10-17 Ortho Mcneil Pharmaceutical, Inc. Combination therapy comprising glucose reabsorption inhibitors and ppar modulators
DE60233655D1 (de) 2001-04-04 2009-10-22 Ortho Mcneil Janssen Pharm R und retinoid x rezeptorenmodulatoren
FR2838968A1 (fr) * 2002-04-30 2003-10-31 Lipha Association d'insuline et d'un derive de thiazolidinedione et son utilisation pour traiter le diabete
CA2488699A1 (en) * 2002-06-12 2003-12-24 Sumitomo Pharmaceuticals Co., Ltd. Indole, indazole, and benzazole derivative

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04501722A (ja) * 1988-11-14 1992-03-26 ジ・アップジョン・カンパニー 抗―糖尿病、抗―肥満症および抗―アテローム性動脈硬化症薬として有用なα―アミノ―インドール―３―酢酸
AU651571B2 (en) * 1990-02-09 1994-07-28 Pharmacia & Upjohn Company Use of insulin sensitizing agents to treat hypertension
DK0801059T3 (da) * 1994-11-29 2001-09-24 Dainippon Pharmaceutical Co Indolderivat

Also Published As

Publication number Publication date
NO20021036D0 (no) 2002-03-01
KR20020063555A (ko) 2002-08-03
WO2001017513A3 (en) 2001-09-20
EP1212090A2 (en) 2002-06-12
AU6868000A (en) 2001-04-10
HK1044711A1 (zh) 2002-11-01
PE20010580A1 (es) 2001-05-25
WO2001017513A2 (en) 2001-03-15
AR031674A1 (es) 2003-10-01
CA2383946A1 (en) 2001-03-15
NO20021036L (no) 2002-04-26
HUP0203285A3 (en) 2003-02-28
PL354295A1 (en) 2004-01-12
RU2002108346A (ru) 2003-11-20
CN1372476A (zh) 2002-10-02
HUP0203285A2 (hu) 2003-01-28

Similar Documents

Publication Publication Date Title
AR056445A1 (es) Derivados arilicos y heteroarilicos de 6 miembros para tratar virus
RS50933B (sr) Izoindolin-1-on aktivatori glukokinaze
EA200201179A1 (ru) Производные 2-аминокарбонил-9h-пурина
CO5261551A1 (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas
PE20090550A1 (es) Composicion farmaceutica solida que comprende un derivado de bencimidazol y un agente de control de ph
ES2655026T3 (es) Compuestos farmacológicamente activos
AR043063A1 (es) Bencimidazoles 6-sustituidos y su uso como inhibidores de secreciones gastricas
AR028531A1 (es) Compuestos organicos
NO20064309L (no) Azabicyklo(3.1.0)heksanderivater anvendelige som modulatorer for dopamin D3 receptorer
BR0111991A (pt) Antagonistas de receptor de trombina
PE20040914A1 (es) Derivados de pirrolopirimidina como inhibidores de tirosina quinasas
CO5261589A1 (es) Compuestos heterociclicos, su produccion y su utilizacion
BR9103802A (pt) Composto,processo para a preparacao do mesmo e composicao farmaceutico
AR049443A1 (es) Derivados de pirrolpiridinas
AR035639A1 (es) Derivados de para-aril o heterociclil sustituidos activadores de fenilglucoquinasa, un proceso para su preparacion, composicion farmaceutica y el uso de dichos derivados para la preparacion de medicamentos.
CO5200848A1 (es) Derivados de 3(5)-ureido-pirazol, proceso para su prepa- racion y su utilizacion como agentes antitumorales
AR063073A1 (es) Inhibidor de la activacion de stat 3/5
BRPI0615158A8 (pt) composto, composição farmacêutica, e, métodos para tratar ou prevenir uma doença ou condição, e para preparar um composto.
AR072045A1 (es) Derivados heterociclicos de urea y metodos para utilizarlos
BR0109991A (pt) Composição farmacêutica
AR018159A1 (es) Compuestos derivados de amidin-amino-acidos halogenados utiles como inhibidores de la oxido-nitrico-sintetasa, composicion farmaceutica que los contiene ymetodo de tratamiento
BRPI0417948A (pt) derivados de quinuclidina substituìda por bicicloheterociclo fundido
CL2011000784A1 (es) Compuestos derivados de 7-h-pirazoli[3,4-e]-diasepina-6(5h)-ona sustituidos; procedimiento de preparacion; composicion farmaceutica, utiles como agentes antibacteriales.
MX2007003105A (es) Derivados de bencimidazol, composiciones que los contienen, sus preparaciones y sus usos i.
CO5180632A1 (es) Composicion farmaceutica dos de tiazolidindiona u oxazolidindiona y derivados de in- dol.

Legal Events

Date Code Title Description
FC Application refused